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Background: The accuracy of the World Health Organization method of estimating malaria parasite density from
thick blood smears by assuming a white blood cell (WBC) count of 8,000/μL has been questioned in several studies.
Since epidemiological investigations, anti-malarial efficacy trials and routine laboratory reporting in Papua New
Guinea (PNG) have all relied on this approach, its validity was assessed as part of a trial of artemisinin-based
combination therapy, which included blood smear microscopy and automated measurement of leucocyte densities
on Days 0, 3 and 7.
Results: 168 children with uncomplicated malaria (median (inter-quartile range) age 44 (39–47) months) were
enrolled, 80.3% with Plasmodium falciparum monoinfection, 14.9% with Plasmodium vivax monoinfection, and 4.8%
with mixed P. falciparum/P. vivax infection. All responded to allocated therapy and none had a malaria-positive slide
on Day 3. Consistent with a median baseline WBC density of 7.3 (6.5-7.8) × 109/L, there was no significant difference
in baseline parasite density between the two methods regardless of Plasmodium species. Bland Altman plots
showed that, for both species, the mean difference between paired parasite densities calculated from assumed
and measured WBC densities was close to zero. At parasite densities <10,000/μL by measured WBC, almost all
between-method differences were within the 95% limits of agreement. Above this range, there was increasing
scatter but no systematic bias.
Conclusions: Diagnostic thresholds and parasite clearance assessment in most PNG children with uncomplicated
malaria are relatively robust, but accurate estimates of a higher parasitaemia, as a prognostic index, requires formal
WBC measurement.
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Although the effect of malaria infection and its treatment
on erythrocyte dynamics in humans is well characterized
[1,2], there are limited equivalent data on non-erythrocytic
haematological indices. Increasing evidence suggests that
changes in white blood cell (WBC) densities depend on
both the geographical setting and the infecting species of* Correspondence: tim.davis@uwa.edu.au
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unless otherwise stated.Plasmodium [3-6]. An important practical implication of
this is for malaria microscopy, which remains the main
method of diagnosing malaria and in which a WBC density
is required for thick film quantification of parasite density.
As well as being a key variable in epidemiological and
pharmaceutical intervention trials, the accurate estimation
of parasitaemia is important in assessing prognosis in both
children [7] and adults [8].
The microscopy method recommended by the World
Health Organization (WHO) to estimate asexual parasite
density is to multiply the parasite count for a given thickLtd. This is an Open Access article distributed under the terms of the Creative
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peripheral blood WBC count of 8,000/μL [9]. However,
some authors have raised concerns regarding its accuracy
[5,10-13]. In Papua New Guinea (PNG), epidemiological
studies, anti-malarial efficacy trials and routine laboratory
reporting have all relied on parasite density calculations
based on an assumed WBC density of 8,000/μL regardless
of Plasmodium species [14-18]. The validity of this ap-
proach was assessed by using data collected as part of a
trial of artemisinin-based combination therapy in PNG
children with uncomplicated malaria in which blood
smears were taken and WBC densities measured at study
entry and during follow-up as part of efficacy and safety
assessment.
Methods
Children aged 0.5 to 5 years with uncomplicated malaria
were recruited at Mugil and Alexishafen Health Centres
in Madang Province on the north coast of mainland
PNG between April 2011 and June 2012 during a ran-
domized comparative efficacy trial of the artemisinin-
based combination therapies artemether-lumefantrine
and artemisinin-naphthoquine (Australian New Zealand
Clinical Trials Registry ACTRN12610000913077) [19].
Inclusion criteria included: i) an axillary temperature >
37.5°C or fever during the previous 24 hours, ii) Plasmo-
dium falciparum (> 1,000 asexual parasites/μL whole
blood) and/or Plasmodium vivax (> 250/ μL) on a per-
ipheral blood smear, and iii) no clinical or laboratory evi-
dence of severe malaria or other infection according to
WHO severity criteria [20]. The study was approved by
the PNG Institute of Medical Research Institutional Re-
view Board and the Medical Research Advisory Commit-
tee of the PNG Department of Health (MRAC 10.39).
Written informed consent was obtained from parents or
guardians prior to enrolment of children. All patients
were treated with artemisinin-based combination ther-
apy for three days starting on Day 0. Serial clinical as-
sessments were performed by trained research nurses
and/or clinicians, and the results documented on stan-
dardized case report forms. These assessments included
haematological investigations and malaria microscopy
on Days 3 and 7.
On Days 0, 3 and 7, venous blood samples were col-
lected into EDTA-containing Microtainer® tubes (Becton,
Franklin Lakes, USA) and full blood counts were per-
formed on the same day using a multichannel analyser
(ACT diff, Beckman Coulter, Brea, USA). Leucocytosis
was defined as a WBC density of ≥ 10.0 × 109/L, leucopae-
nia as < 4.0 × 109/L and thrombocytopaenia as a platelet
density < 100 × 109/L. White blood cell differentials were
estimated as percentages with normal lymphocyte, mono-
cyte and granulocyte ranges of 20.5-51.1%, 1.7-9.3% and
42.2-75.2%, respectively.Of the three blood slides per patient prepared as part
of each blood collection, one was stained with 10% v/v
Giemsa over 10 minutes and read on site under 100 ×
magnification by a skilled microscopist to determine
patient eligibility. The remaining slides were transported
to a reference microscopy laboratory where they were
stained with 4% v/v Giemsa stain over 30 minutes and
subsequently read independently by two skilled micros-
copists, who were blinded to the initial result. Parasit-
aemia was quantified using the numbers of parasites
identified in fields containing a total of 200 WBC in
high-density smears or 500 WBC in low density smears.
Negative slides were those in which no parasites were
observed after examination of 200 fields under 100 ×
magnification. Slides with discrepancies of more than a
factor of three regarding density, speciation and/or para-
site positivity/negativity were adjudicated by a senior
microscopist. Parasite densities were calculated as i) as-
sumed = (parasites counted ÷ number of WBC counted) ×
8,000 and ii) confirmed = (parasites counted ÷ number of
WBC counted) × (WBC measured by analyser).
Data were analysed using non-parametric methods
with a two-tailed significance level of P < 0.05. Bland
Altman plots were constructed with parasite densities
calculated from measured WBC densities used as the
gold standard [21].
Results
Over a 14-month period, 168 children with uncompli-
cated malaria were enrolled of whom 165 and 164
returned on days 3 and 7, respectively, for follow-up.
Their median (inter-quartile range) age was 44 (39–47)
months, 49% were males and 55% had a palpable spleen
at the time of enrolment. Twenty-five (14.9%) had P.
vivax monoinfection, 8 (4.8%) had mixed P. falciparum/
P. vivax infection, while the remaining 80.3% had a
P. falciparum monoinfection. All patients responded to
their allocated therapies and none of the children had a
malaria-positive slide on Day 3 of follow-up. There were
also significant falls in axillary temperature, pulse rate and
respiratory rate during this time (see Table 1). There were
no complications related to malaria or its treatment, or
deaths (full data to be presented subsequently).
Most of the children were anaemic at presentation
with a transient further fall in haemoglobin to Day 3 be-
fore recovery by Day 7 (see Table 1). The prevalence of
leucopenia declined significantly as patients recovered
but there was no change in the prevalence of leucocyt-
osis during the one-week follow-up period. More than
half of the children had thrombocytopaenia on the day
of enrolment but this had dropped to 3% by Day 7.
The proportion of children with palpable splenomeg-
aly declined over the week (55% on Day 0 vs 15% on
Day 7; P < 0.0001).








Axillary Temperature (°C) 38.1 (37.8-38.3) 36.3 (36.2-36.5) 36.6 (36.5-36.6) < 0.001
Respiratory rate (/min) 32 (30–32) 28 (28–28) 28 (28–28) < 0.001
Pulse rate (/min) 124 (120–128) 108 (104–109) 104 (103.8-108) < 0.001
Haemoglobin (g/L) 79 (75–82) 72 (70–75) 78.5 (75–81) 0.003
Total WBC (× 109/L) 7.3 (6.5-7.8) 7.1 (6.6-7.4) 8.3 (7.9-8.7) < 0.001
Leucopaenia (%) 8.3 4.8 2.4 0.015
Leucocytosis (%) 16.1 7.9 17.7 0.71
Lymphocytes (%) 34 (29–40) 50 (47–52) 45 (43–47) < 0.001
Monocytes (%) 8 (7–9) 10 (8–11) 8 (6–9) 0.034
Granulocytes (%) 44 (38–46) 32 (30–34) 38 (35–39) < 0.001
Platelet density (× 109/L) 92 (81–107) 143.5 (130–158) 257 (240–288) < 0.001
Thrombocytopaenia (%) 53 22.4 3 < 0.001
Data are median and (interquartile range) or percentages.
*Kruskal Wallis test.
Figure 1 Box plot showing median, interquartile range,
minimum and maximum leucocyte counts in children with
falciparum monoinfection (grey boxes) compared to those with
vivax monoinfection (white boxes) during the one-week
follow-up period. Outlying values are shown as open circles. There
were no significant differences between the two groups on Days 0,
3 and 7 (P = 0.18, 0.34 and 0.051, respectively).
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to Day 0 (P < 0.001) but there was no significant differ-
ence between Days 0 and 3 (P = 0.81). Excluding those
with mixed-species infections, children with falciparum
malaria had lower median leucocyte counts at all time-
points compared to those with vivax malaria, but the
differences were not statistically significant (P > 0.05 in
each case; Figure 1). In patients with falciparum malaria,
9%, 4.5% and 3% were leucopaenic on Days 0, 3 and 7
respectively, while 6% of children with vivax malaria
were leucopaenic on Days 0 and 3, and none were
leucopaenic by Day 7. Although there were significant
changes in WBC differentials over the course of the
one-week period, these changes were all within normal
ranges, except for a slightly elevated monocyte count on
Day 3 (Table 1).
There was no significant difference in baseline para-
site density between the two methods regardless of
Plasmodium species (see Table 2). Bland Altman plots
showed that, for both P. falciparum and P. vivax, the
mean difference between paired parasite densities cal-
culated from an assumed and a measured WBC dens-
ity was close to zero in each case (see Figures 2 and 3).
At parasite densities by measured WBC that were <
10,000/μL, and for P. falciparum up to 100,000/μL,
almost all between-method differences were well within
the 95% limits of agreement. At parasite densities
above these ranges, there were increasing numbers of
co-ordinates outside the 95% limits of agreement.
However, there was no pattern to their distribution,
indicating that the use of an assumed WBC density
of 8,000/μL was not associated with systematic bias,
even at the highest parasitaemia.Discussion
The present study, which is the first of its kind from the
Oceania region, shows that parasite densities derived
using an assumed WBC of 8,000/μL in PNG children
with uncomplicated P. falciparum or P. vivax infections
appear reliable when the parasitaemia is < 10,000/μL.
Table 2 Baseline parasite density calculated using an assumed WBC count of 8,000/μL compared to absolute WBC
counts determined in individual children
Parasite density based on assumed WBC count Parasite density based on measured WBC count P value*
P. falciparum (n = 143) 15,208 (9,320-19,470) 13,213 (7,680-16,273) 0.49
P. vivax (n = 33) 5,364 (644-10,109) 3,538 (595-12,698) 0.96
Data are median (interquartile range). Children with mixed Plasmodium falciparum/Plasmodium vivax infections (n = 8) are included in both groups.
*Mann–Whitney U test.
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differences in parasitaemia between assumed and measured
WBC densities can be large, especially in P. falciparum in-
fections with a parasitaemia > 100,000/μL. The practical
implications of these observations are that thresholds for
diagnosis and the assessment of parasite clearance in most
children with uncomplicated malaria are relatively robust,
but that an accurate estimate of higher parasitaemias as a
prognostic index in more severely ill children requires for-
mal WBC measurement [9].
Consistent with the overall similarity between the two
methods, the median measured total leucocyte density
in our patients was close to the assumed 8,000/μL at
study entry. A recent study from Ghana suggested that a
leucocyte count of 10,000/μL was an appropriate as-
sumed leucocyte count for the determination of parasite
density because of significant underestimation associated
with 8,000/μL [11]. Although this conclusion was based
on a large sample size with pooled data from three sep-
arate studies, non-malarial causes of leucocytosis such as
bacterial co-infection, which appears relatively common
in African settings [22,23], were not excluded. However,
in another African study, parasite density based on
an assumed leucocyte count of 8,000/μL resulted in aFigure 2 Bland Altman plot showing parasite densities estimated usin
Plasmodium falciparum cases (abscissa) and the difference in parasite
(ordinate axis). The mean difference (solid line) and 95% limits of agreemsignificant overestimation of parasite burden in Ghanaian
children [24]. In this study, manual methods were used
to quantify WBC and the authors used parametric statis-
tical tests, which may have been inappropriate give the
distribution of data. A study of Thai adults with falcip-
arum malaria showed that one-sixth had leucopaenia
and that the use of an assumed leucocyte count over-
estimated parasite densities in nearly one-third of pa-
tients [5]. The disparate results of these and the present
study highlight the need for local data on WBC densities
before the WHO method of quantification of parasitaemia
is adopted [9].
Both the African paediatric studies [11,24] were cross-
sectional and did not report follow-up WBC counts or
clinical outcome data that may have facilitated an assess-
ment of whether malaria was the sole cause of WBC
changes at baseline. In the present sample, < 25% of chil-
dren with strictly defined uncomplicated malaria had
either a leucopenia or leukocytosis at presentation and
this overall percentage did not change appreciably dur-
ing the next 7 days based on near-complete follow-up
data. This suggests that co-incident infections other than
malaria, either ongoing or resolving, did not influence
WBC densities in the majority of the present children.g measured white blood cell densities on a logarithmic scale for
density from assumed and measured leucocyte densities
ent (dashed lines) are also shown.
Figure 3 Bland Altman plot showing parasite densities estimated using measured white blood cell densities on a logarithmic
scale for Plasmodium vivax cases (abscissa) and the difference in parasite density from assumed and measured leucocyte
densities (ordinate axis). The mean difference (solid line) and 95% limits of agreement (dashed lines) are also shown.
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Days 0 and 3 suggests that an assumed 8,000/μL could
be validly applied for quantitative assessment of parasite
clearance which was typically well within 48 hours in the
present study.
There was no significant difference in WBC density
between children with falciparum malaria and those with
vivax malaria in the present study. Some studies have
suggested that falciparum malaria is associated with a
lower WBC density than vivax malaria [4,5] (consistent
with the non-significantly lower medians in children
with falciparum malaria in our serial data to Day 7), but
others have found no difference [6]. In any case, the ab-
solute difference is of dubious clinical significance [4] es-
pecially since a low density may not reflect deficiency
but rather localization of leucocytes away from the per-
ipheral circulation in the spleen and other marginal
pools [25]. The significant decline in splenomegaly rates
between Days 0 and 7 in our children and the parallel
normalization of leucocyte counts by Day 7 support this
hypothesis.
Conclusions
The present study shows that P. falciparum and P. vivax
parasite densities estimated using an assumed leucocyte
count of 8000/μL are reliable for children without hyper-
parasitaemia (< 100,000/μL). This is an important and
reassuring finding for epidemiological and intervention
studies, as well as routine laboratories, in PNG. Although
leucocyte densities should ideally be determined in tan-
dem with each thick film in individual patients [26], auto-
mated haematological analysers are costly and require
disposables, regular maintenance, a reliable power supplyand appropriately trained operators. In addition, the
manual leucocyte counting method is laborious, subject-
ive and can be inaccurate. The present data confirm that
valid parasitaemia data can be collected in situations in
PNG, and perhaps other countries with similar malaria
epidemiology in the Oceania region, in which there is
limited or no capacity to perform manual or automated
WBC densities.
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